Cargando…
Drug repurposing screens to identify potential drugs for chronic kidney disease by targeting prostaglandin E2 receptor
Renal inflammation and fibrosis are significantly correlated with the deterioration of kidney function and result in chronic kidney disease (CKD). However, current therapies only delay disease progression and have limited treatment effects. Hence, the development of innovative therapeutic approaches...
Autores principales: | Huang, Hung-Jin, Lee, Yu-Hsuan, Sung, Li-Chin, Chen, Yi-Jie, Chiu, Yu-Jhe, Chiu, Hui-Wen, Zheng, Cai-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362296/ https://www.ncbi.nlm.nih.gov/pubmed/37484490 http://dx.doi.org/10.1016/j.csbj.2023.07.007 |
Ejemplares similares
-
Nicotine Causes Nephrotoxicity through the Induction of NLRP6 Inflammasome and Alpha7 Nicotinic Acetylcholine Receptor
por: Zheng, Cai-Mei, et al.
Publicado: (2020) -
Virtual screening on the web for drug repurposing: a primer
por: Chen, Yu Wai, et al.
Publicado: (2021) -
Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant Acinetobacter baumannii
por: Cheng, Yu-Shan, et al.
Publicado: (2019) -
Large-Scale Drug Screen Identifies FDA-Approved Drugs for Repurposing in Sickle-Cell Disease
por: Cannon, Matthew, et al.
Publicado: (2020) -
Genomic-Analysis-Oriented Drug Repurposing in the Search for Novel Antidepressants
por: Lesmana, Mohammad Hendra Setia, et al.
Publicado: (2022)